Jeffrey A. Hubbell
Founder at Kanyos Bio, Inc.
Jeffrey A. Hubbell active positions
Companies | Position | Start | End |
---|---|---|---|
École Polytechnique Fédérale de Lausanne | Corporate Officer/Principal | 25/03/2009 | - |
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Director/Board Member | 14/06/2018 | - |
Founder | - | - | |
Chairman | 31/12/2012 | 14/06/2018 | |
Chief Tech/Sci/R&D Officer | - | 14/06/2018 | |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
Founder | 01/01/2015 | - | |
Chairman | 01/01/2015 | - | |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Director/Board Member | - | - |
Founder | - | - | |
Corporate Secretary | - | - |
Career history of Jeffrey A. Hubbell
Former positions of Jeffrey A. Hubbell
Companies | Position | Start | End |
---|---|---|---|
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | Corporate Officer/Principal | - | - |
Swiss Federal Institute of Technology | Corporate Officer/Principal | - | - |
The University of Texas at Austin | Corporate Officer/Principal | - | - |
Kuros Biosurgery Holding AG
Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosurgery Holding AG operated as a medical technology company. It engaged in the development of biologic and biomaterial-based product candidates for localized therapy in trauma, spine and wound care. The company was founded by Marion Bavand, Didier Cowling, Dominik Ellenrieder, and Jeffrey Hubbel on April 3, 2008 and was headquartered in Zurich, Switzerland. | Director/Board Member | 01/01/2002 | - |
Chief Tech/Sci/R&D Officer | 01/01/2002 | 17/07/2009 | |
Founder | 01/01/2002 | - |
Statistics
International
United States | 5 |
Switzerland | 4 |
Germany | 2 |
Operational
Director/Board Member | 4 |
Founder | 4 |
Corporate Officer/Principal | 4 |
Sectoral
Consumer Services | 5 |
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Kuros Biosurgery Holding AG
Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosurgery Holding AG operated as a medical technology company. It engaged in the development of biologic and biomaterial-based product candidates for localized therapy in trauma, spine and wound care. The company was founded by Marion Bavand, Didier Cowling, Dominik Ellenrieder, and Jeffrey Hubbel on April 3, 2008 and was headquartered in Zurich, Switzerland. | Commercial Services |
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Health Technology |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Health Technology |
- Stock Market
- Insiders
- Jeffrey A. Hubbell
- Experience